CEO: Alexander Macrae

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Sangamo Therapeutics Inc is a clinical stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy.


Key numbers

Market Capitalization:1133873640
Shares Outstanding: 115938000
Float: 115766179.884
Next Earning Date:2020-02-07
TTm EPS: -1.0958
TTm Dividend Rate:
200 days moving average:10.35
50 days moving average: 9.48
One day percent Change: 3.34



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,